Modulation of urokinase-type plasminogen activator messenger RNA levels in human synovial fibroblasts by interleukin-1, retinoic acid, and a glucocorticoid

Arthritis Rheum. 1988 Aug;31(8):1046-51. doi: 10.1002/art.1780310817.

Abstract

Previous studies have shown that mononuclear cell-conditioned medium (MCCM), interleukin-1 (IL-1), and all-trans-retinoic acid rapidly stimulate, while glucocorticoids lower, the urokinase-type plasminogen activator (u-PA) activity of human synovial fibroblast-like cells. It is now reported that MCCM, recombinant human IL-1 alpha (rHuIL-1 alpha), rHuIL-1 beta, and all-trans-retinoic acid elevate the u-PA messenger RNA (mRNA) levels to a steady-state value within 2 hours, while dexamethasone (10(-7)M) inhibits this increase. For both situations, when the u-PA activity is either stimulated or reduced, the changes in the u-PA mRNA levels parallel the changes in the u-PA activity, and it is suggested that modulation of gene transcription plays an important role.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cells, Cultured
  • Culture Media
  • Dexamethasone / pharmacology*
  • Enzyme Precursors / genetics*
  • Fibroblasts / drug effects
  • Humans
  • Interleukin-1 / pharmacology*
  • Plasminogen Activators / genetics*
  • RNA, Messenger / drug effects*
  • Recombinant Proteins / pharmacology
  • Synovial Membrane / cytology*
  • Time Factors
  • Transcription, Genetic / drug effects
  • Tretinoin / pharmacology*
  • Urokinase-Type Plasminogen Activator / genetics*

Substances

  • Culture Media
  • Enzyme Precursors
  • Interleukin-1
  • RNA, Messenger
  • Recombinant Proteins
  • Tretinoin
  • Dexamethasone
  • Plasminogen Activators
  • Urokinase-Type Plasminogen Activator